Literature DB >> 6780061

Hypercalcaemia and angioimmunoblastic lymphadenopathy.

E Gan, M B Van der Weyden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6780061      PMCID： PMC1504264          DOI： 10.1136/bmj.282.6262.437

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Treatment of hypercalcemia associated with malignancy.

Authors:  E L Mazzaferri; T M O'Dorisio; A F LoBuglio
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

2.  Hypercalcemia in malignant lymphoma and leukemia.

Authors:  G P Canellos
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

3.  Malignant lymphoma arising in angioimmunoblastic lymphadenopathy.

Authors:  B N Nathwani; H Rappaport; E M Moran; G A Pangalis; H Kim
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

4.  Mechanisms of hypercalcemia in malignancy.

Authors:  A Besarab; J F Caro
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

Review 5.  Lymphadenopathy associated with dysgammaglobulinemia.

Authors:  W Pruzanski
Journal:  Semin Hematol       Date:  1980-01       Impact factor: 3.851
  5 in total
  1 in total

1.  Sequential Complications of Hypercalcemia, Necrotizing Granulomatous Vasculitis, and Aplastic Anemia Occurring in One Patient with Angioimmunoblastic T-cell Lymphoma.

Authors:  Sriman Swarup; Jonathan Kopel; Kyaw Zin Thein; Kaiser Tarafdar; Khatrina Swarup; Seshadri Thirumala; Donald P Quick
Journal:  Am J Med Sci       Date:  2020-09-03       Impact factor: 3.462
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.